查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1654683

全球双能量 X 射线吸收仪市场 - 2025 至 2033 年

Global Dual Energy X-Ray Absorptiometry Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 157 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024 年全球双能量 X 射线吸收法 (DEXA) 市场规模达到 2.529 亿美元，预计到 2033 年将达到 3.875 亿美元，在 2025-2033 年预测期内的复合年增长率为 4.9%。

双能量 X 射线吸收仪 (DEXA) 是一种非侵入性医学影像技术，主要用于评估骨矿物质密度 (BMD) 和身体组成。它的工作原理是测量两种不同能量水平的X射线穿过人体时的吸收情况。此方法可以根据骨组织和软组织（如肌肉和脂肪）吸收 X 光的方式精确区分它们。该系统使用两束不同能量的X射线来扫描身体。两种能量水平之间的吸收差异可以准确测量骨密度和软组织成分。

双能量X 射线吸收仪 (DEXA) 的市场需求受到医疗保健领域的各种全球趋势和需求的影响，特别是在骨骼健康、身体组成分析和骨质疏鬆症管理领域。例如，根据骨骼健康与骨质疏鬆基金会的数据，在美国，约有 1,000 万人患有骨质疏鬆症，估计有 4,400 万人患有低骨密度（骨质减少症），随着人口老化，这一数字预计还会增加。骨质疏鬆症是老年人骨折的主要原因之一。随着全球人口老化，对 DEXA 扫描进行骨质疏鬆症筛检的需求显着增加。

市场动态：

驱动因素与约束因素

骨质疏鬆症和骨骼疾病盛行率上升

骨质疏鬆症和骨骼疾病盛行率的上升极大地推动了双能量X射线吸收仪（DEXA）市场的成长，预计将在预测期内推动市场的发展。骨质疏鬆症的特征是骨矿物质密度（BMD）降低，会导致骨骼变脆弱，增加骨折风险。它在老年族群中尤其常见，尤其是停经后妇女。

例如，根据国际骨质疏鬆基金会（IOF）的数据，50岁以上的女性中大约有三分之一、男性中大约有五分之一的人在其一生中会经历骨质疏鬆性骨折。此外，根据骨骼健康与骨质疏鬆基金会的数据，在美国，有近1,000万人患有骨质疏鬆症，另有4,400万人因骨密度低而面临风险。这种广泛的流行凸显了早期检测和定期筛检的必要性，从而增加了对 DEXA 的需求。

随着全球人口老化，骨骼健康筛检的需求不断增加。根据世界卫生组织的数据，到 2050 年，60 岁及以上人口的数量预计将增加到 20 亿以上，其中许多人面临骨质疏鬆症的风险。老年人更容易出现骨质减少或骨质疏鬆等骨骼健康问题，从而推动对 DEXA 扫描进行早期诊断和监测的需求。

DEXA 设备成本高

DEXA 设备的高成本是双能量 X 射线吸收仪 (DEXA) 市场成长的重大障碍。 DEXA 机器的价格通常在 20,000 美元到 100,000 美元以上之间，具体取决于型号、功能和品牌。由于前期投资庞大，小型医疗机构、乡村诊所和低收入地区的医院难以负担此类设备。小型诊所和初级保健机构可能会发现，投资 DEXA 机器在财务上不可行，特别是在医疗资金有限或骨密度筛检尚未普及的地区。

除了最初的购买价格外，营运成本（例如电力、员工培训和定期维护）也增加了负担。维护 DEXA 机器需要熟练的人员、专门的校准和定期维修，这进一步增加了医疗保健提供者的营运费用。例如，中低收入国家 (LMIC) 的医疗保健中心可能难以满足维护要求，从而导致 DEXA 设备利用不足或故障。

DEXA 机器的高成本也为诸如基于超音波的骨密度仪或定量电脑断层扫描 (QCT) 等替代技术提供了优势，这些技术成本较低且越来越多地用于筛检。例如，基于超音波的设备更实惠（价格通常低于 10,000 美元）并提供无辐射的替代方案，使其成为预算有限的医疗保健提供者的有吸引力的选择。

目录

第一章：市场介绍和范围

  • 报告目标
  • 报告范围和定义
  • 报告范围

第 2 章：高阶主管见解与关键要点

  • 市场亮点和战略要点
  • 主要趋势和未来预测
  • 按产品类型分类的片段
  • 可移植性片段
  • 按应用程式截取的程式码片段
  • 最终用户的程式码片段
  • 按地区分类的片段

第 3 章：动态

  • 影响因素
    • 驱动程式
      • 骨质疏鬆症和骨骼疾病盛行率上升
    • 限制
      • DEXA 设备成本高昂
    • 机会
    • 影响分析

第四章：战略洞察与产业展望

  • 市场领导者和先驱者
    • 新兴先锋和杰出参与者
    • 拥有最大销售品牌的成熟领导者
    • 拥有成熟产品的市场领导者
  • 新兴创业公司和关键创新者
  • CXO 观点
  • 最新进展与突破
  • 案例研究/正在进行的研究
  • 监管和报销情况
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 波特五力分析
  • 供应链分析
  • 专利分析
  • SWOT 分析
  • 未满足的需求和差距
  • 市场进入和扩张的推荐策略
  • 情境分析：最佳情况、基本情况和最坏情况预测
  • 定价分析和价格动态

第 5 章：双能量 X 射线吸收仪 (DEXA) 市场（依产品类型）

  • 中央双能量X射线吸收仪
  • 外周双能量X射线吸收仪

第 6 章：双能量 X 射线吸收仪 (DEXA) 市场，以便携性划分

  • 独立
  • 便携的

第 7 章：双能量 X 射线吸收仪 (DEXA) 市场（按应用）

  • 骨密度测定
  • 骨质疏鬆症
  • 骨折处理
  • 其他的

第 8 章：双能量 X 射线吸收仪 (DEXA) 市场（按最终用户）

  • 医院
  • 专科诊所
  • 诊断中心
  • 其他的

第 9 章：双能量 X 射线吸收仪 (DEXA) 市场，按区域市场分析和成长机会

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第 10 章：竞争格局与市场定位

  • 竞争概况和主要市场参与者
  • 市占率分析与定位矩阵
  • 策略伙伴关係、併购
  • 产品组合和创新的关键发展
  • 公司基准化分析

第 11 章：公司简介

  • GE HealthCare
    • 公司概况
    • 产品组合和描述
    • 财务概览
    • 关键进展
    • SWOT 分析
  • Hologic, Inc.
  • OSTEOSYS Corp.
  • DMS Group
  • Swissray International, Inc.
  • Xuzhou Pinyuan Electronic Technology Co., Ltd.
  • FUJIFILM Holdings Corporation
  • Scintica Instrumentation, Inc.
  • IDETEC MEDICAL IMAGING
  • Trivitron Healthcare

第 12 章：假设与研究方法

  • 资料收集方法
  • 数据三角测量
  • 预测技术
  • 数据验证和确认

第 13 章：附录

简介目录
Product Code: MD7679

The global Dual Energy X-Ray Absorptiometry (DEXA) market reached US$ 252.9 million in 2024 and is expected to reach US$ 387.5 million by 2033, growing at a CAGR of 4.9% during the forecast period 2025-2033.

Dual-Energy X-Ray Absorptiometry (DEXA) is a non-invasive medical imaging technique used primarily for assessing bone mineral density (BMD) and body composition. It works by measuring the absorption of X-rays at two different energy levels as they pass through the body. This method allows for precise differentiation between bone tissue and soft tissue (such as muscle and fat) based on how they absorb X-rays. The system uses two X-ray beams with different energy levels to scan the body. The difference in absorption between the two energy levels allows for accurate measurement of bone density and soft tissue composition.

The market demand for Dual-Energy X-Ray Absorptiometry (DEXA) is shaped by various global trends and needs in healthcare, particularly in the fields of bone health, body composition analysis and osteoporosis management. For instance, according to the Bone Health & Osteoporosis Foundation, in the U.S., approximately 10 million people have osteoporosis, and an estimated 44 million people have low bone density (osteopenia), with a projected increase as the population ages. Osteoporosis is one of the leading causes of bone fractures among the elderly. As the global population ages, the demand for DEXA scans for osteoporosis screening has significantly increased.

Market Dynamics: Drivers & Restraints

Rising prevalence of osteoporosis and bone disorders

The rising prevalence of osteoporosis and bone disorders is significantly driving the growth of the Dual Energy X-Ray Absorptiometry (DEXA) market and is expected to drive the market over the forecast period. Osteoporosis, characterized by reduced bone mineral density (BMD), leads to weaker bones and an increased risk of fractures. It is especially common among elderly populations, particularly post-menopausal women.

For instance, according to the International Osteoporosis Foundation (IOF), approximately 1 in 3 women over the age of 50 years and 1 in 5 men will experience osteoporotic fractures in their lifetime. Moreover, according to the Bone Health & Osteoporosis Foundation, in the United States, nearly 10 million people suffer from osteoporosis, and an additional 44 million are at risk due to low bone density. This wide prevalence underscores the need for early detection and regular screening, which boosts the DEXA demand.

As populations age globally, the demand for bone health screening increases. By 2050, the number of people aged 60 and older is expected to rise to over 2 billion according to the World Health Organization, with many in this group at risk of osteoporosis. Elderly individuals are more likely to develop bone health issues such as osteopenia or osteoporosis, driving the demand for DEXA scans for early diagnosis and monitoring.

High cost of the DEXA devices

The high cost of DEXA devices is a significant barrier to the growth of the Dual-Energy X-Ray Absorptiometry (DEXA) market. The price of a DEXA machine typically ranges from $20,000 to over $100,000, depending on the model, features, and brand. This steep initial investment makes it difficult for smaller healthcare facilities, rural clinics, and hospitals in low-income regions to afford such equipment. Small clinics and primary care practices may find it financially unfeasible to invest in DEXA machines, especially in regions with limited healthcare funding or where bone density screening is not yet a widespread practice.

Aside from the initial purchase price, operational costs (such as electricity, staff training, and regular maintenance) add to the burden. Maintaining a DEXA machine requires skilled personnel, specialized calibration, and periodic servicing, which further increases operational expenses for healthcare providers. For instance, healthcare centers in low- and middle-income countries (LMICs) may struggle to keep up with maintenance requirements, which leads to underutilization or failure of DEXA equipment.

The high cost of DEXA machines also gives an advantage to alternative technologies such as ultrasound-based bone densitometers or quantitative computed tomography (QCT), which are less expensive and increasingly used for screening. For instance, ultrasound-based devices are more affordable (with prices often under $10,000) and offer a radiation-free alternative, making them an attractive option for healthcare providers on a budget.

Segment Analysis

The global Dual Energy X-Ray Absorptiometry (DEXA) market is segmented based on product type, portability, application, end-user and region.

Product Type:

The central dual energy x-ray absorptiometry segment is expected to dominate the Dual Energy X-Ray Absorptiometry (DEXA) market share

Central DEXA scans are considered the gold standard for bone mineral density (BMD) measurement, as they provide highly accurate and reproducible results compared to peripheral DEXA or other diagnostic methods. The spine and hip are the primary sites where bone loss occurs, and measuring BMD in these regions offers a reliable assessment of fracture risk. For instance, the International Osteoporosis Foundation (IOF) and National Osteoporosis Foundation (NOF) strongly endorse central DEXA scanning for the early detection of osteoporosis and its progression, making it the most trusted and widely used method in clinical practice.

Central DEXA is widely used in osteoporosis management, as it helps in risk stratification by measuring the bone density of high-risk areas like the spine and hip, where fractures due to osteoporosis are most common. The central segment also plays a significant role in assessing fracture risk and determining the effectiveness of osteoporosis treatments like bisphosphonates, denosumab, or teriparatide. The ability to track changes in BMD over time is critical for tailoring treatment plans.

Geographical Analysis

North America is expected to hold a significant position in the Dual Energy X-Ray Absorptiometry (DEXA) market share

Osteoporosis is a significant health concern in North America especially in the United States, particularly among the elderly population, which drives the demand for bone density screenings and diagnostic tools like DEXA. According to the National Osteoporosis Foundation (NOF), around 10 million people in the U.S. suffer from osteoporosis, and an estimated 44 million people have low bone density (osteopenia), putting them at risk for fractures. This high prevalence of bone disorders significantly contributes to the demand for DEXA scans as the gold standard for diagnosing osteoporosis and assessing fracture risk.

In North America, there is a strong focus on preventive healthcare, and the general population is becoming more aware of the risks of osteoporosis and other bone-related disorders. Organizations like the National Osteoporosis Foundation (NOF) and American Bone Health run continuous public awareness campaigns to educate people about the importance of bone density testing. These initiatives encourage individuals to undergo routine DEXA screenings, thus driving demand for DEXA devices.

North America, particularly the United States and Canada, has some of the most advanced healthcare systems globally. With a high number of hospitals, clinics and specialty centers dedicated to bone health and osteoporosis management, the region has easy access to advanced diagnostic tools like DEXA machines. The U.S. healthcare system is characterized by an extensive network of diagnostic imaging centers, many of which offer DEXA scans as part of routine check-ups, contributing to high market penetration.

Asia-Pacific is growing at the fastest pace in the Dual Energy X-Ray Absorptiometry (DEXA) market

The Asia-Pacific region is home to some of the fastest-aging populations globally. For instance, Japan, China, and India are witnessing a rapid increase in their elderly populations. According to the United Nations, by 2050, the number of people aged 60 years and older in Asia will more than double to 1.3 billion. Osteoporosis and bone health issues become more prevalent with age, making bone density testing a critical part of healthcare in this demographic. The aging population in APAC increases the demand for DEXA scans for osteoporosis detection and fracture risk assessment.

The prevalence of osteoporosis is rising rapidly in many Asia-Pacific countries due to factors such as lifestyle changes, dietary habits and sedentary living. Countries like China and India, despite being home to large populations, have relatively low awareness of osteoporosis, which is leading to an increase in undiagnosed cases. According to the National Institute of Health (NIH), China and India together account for approximately 50% of the world's osteoporotic fractures. As awareness grows about the importance of bone health, the demand for DEXA scans for early diagnosis is increasing.

Competitive Landscape

The major global players in the Dual Energy X-Ray Absorptiometry (DEXA) market include GE HealthCare, Hologic, Inc., OSTEOSYS Corp., DMS Group, Swissray International, Inc., Xuzhou Pinyuan Electronic Technology Co., Ltd., FUJIFILM Holdings Corporation, Scintica Instrumentation, Inc., IDETEC MEDICAL IMAGING, Trivitron Healthcare and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global Dual Energy X-Ray Absorptiometry (DEXA) market report delivers a detailed analysis with 70 key tables, more than 62 visually impactful figures, and 157 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by Portability
  • 2.5. Snippet by Application
  • 2.6. Snippet by End-User
  • 2.7. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Prevalence of Osteoporosis and Bone Disorders
    • 3.1.2. Restraints
      • 3.1.2.1. High Cost of DEXA Devices
    • 3.1.3. Opportunity
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. Emerging Startups and Key Innovators
  • 4.3. CXO Perspectives
  • 4.4. Latest Developments and Breakthroughs
  • 4.5. Case Studies/Ongoing Research
  • 4.6. Regulatory and Reimbursement Landscape
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. Asia Pacific
    • 4.6.4. Latin America
    • 4.6.5. Middle East & Africa
  • 4.7. Porter's Five Force Analysis
  • 4.8. Supply Chain Analysis
  • 4.9. Patent Analysis
  • 4.10. SWOT Analysis
  • 4.11. Unmet Needs and Gaps
  • 4.12. Recommended Strategies for Market Entry and Expansion
  • 4.13. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.14. Pricing Analysis and Price Dynamics

5. Dual Energy X-Ray Absorptiometry (DEXA) Market, By Product Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index, By Product Type
  • 5.2. Central Dual Energy X-ray Absorptiometry*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Peripheral Dual Energy X-ray Absorptiometry

6. Dual Energy X-Ray Absorptiometry (DEXA) Market, By Portability

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
    • 6.1.2. Market Attractiveness Index, By Portability
  • 6.2. Standalone*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Portable

7. Dual Energy X-Ray Absorptiometry (DEXA) Market, By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Bone Densitometry*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Osteoporosis
  • 7.4. Fracture Management
  • 7.5. Others

8. Dual Energy X-Ray Absorptiometry (DEXA) Market, By End-User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.1.2. Market Attractiveness Index, By End-User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Specialty Clinics
  • 8.4. Diagnostic Centers
  • 8.5. Others

9. Dual Energy X-Ray Absorptiometry (DEXA) Market, By Regional Market Analysis and Growth Opportunities

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.7.1. U.S.
      • 9.2.7.2. Canada
      • 9.2.7.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.7.1. Germany
      • 9.3.7.2. U.K.
      • 9.3.7.3. France
      • 9.3.7.4. Spain
      • 9.3.7.5. Italy
      • 9.3.7.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.7.1. Brazil
      • 9.4.7.2. Argentina
      • 9.4.7.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.7.1. China
      • 9.5.7.2. India
      • 9.5.7.3. Japan
      • 9.5.7.4. South Korea
      • 9.5.7.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape and Market Positioning

  • 10.1. Competitive Overview and Key Market Players
  • 10.2. Market Share Analysis and Positioning Matrix
  • 10.3. Strategic Partnerships, Mergers & Acquisitions
  • 10.4. Key Developments in Product Portfolios and Innovations
  • 10.5. Company Benchmarking

11. Company Profiles

  • 11.1. GE HealthCare*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
    • 11.1.5. SWOT Analysis
  • 11.2. Hologic, Inc.
  • 11.3. OSTEOSYS Corp.
  • 11.4. DMS Group
  • 11.5. Swissray International, Inc.
  • 11.6. Xuzhou Pinyuan Electronic Technology Co., Ltd.
  • 11.7. FUJIFILM Holdings Corporation
  • 11.8. Scintica Instrumentation, Inc.
  • 11.9. IDETEC MEDICAL IMAGING
  • 11.10. Trivitron Healthcare

LIST NOT EXHAUSTIVE

12. Assumption and Research Methodology

  • 12.1. Data Collection Methods
  • 12.2. Data Triangulation
  • 12.3. Forecasting Techniques
  • 12.4. Data Verification and Validation

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us